<DOC>
	<DOCNO>NCT00005646</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness paclitaxel treat patient extensive-stage small cell lung cancer .</brief_summary>
	<brief_title>Paclitaxel Treating Patients With Extensive-Stage Small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine complete overall response rate paclitaxel patient previously untreated extensive stage small cell lung cancer . II . Determine overall progression free survival patient response treatment regimen . III . Determine toxicity treatment regimen patient population . OUTLINE : This multicenter study . Patients receive paclitaxel IV 3 hour weekly 6 consecutive week . Treatment continue every 8 week 4 course absence disease progression unacceptable toxicity . Patients follow every 2 month 1 year , every 3 month 2 year , annually 2 year .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm extensive stage small cell carcinoma bronchus Extrathoracic metastatic disease , malignant pleural effusion , bilateral contralateral supraclavicular adenopathy contralateral hilar adenopathy Measurable disease One lesion measure least 20 mm diameter use conventional technique least 10 mm spiral CT scan Lesions consider measurable include : Bone lesion Leptomeningeal disease Ascites Pleural/pericardial effusion Cystic lesion Tumor lesion situate previously irradiate area Abdominal mass confirm followed imaging techniques No disease restrict one hemithorax regional lymph node metastasis , include hilar , ipsilateral contralateral mediastinal , and/or ipsilateral supraclavicular node PATIENT CHARACTERISTICS : Age : 18 Performance status : CTC 02 Life expectancy : Not specify Hematopoietic : Granulocyte count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : SGOT le 2 time upper limit normal Bilirubin le 1.5 mg/dL Renal : Not specify Other : Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : No concurrent hormonal therapy except steroid renal failure hormone administer nondisease related condition Radiotherapy : At least two week since prior radiotherapy No concurrent palliative radiotherapy Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>extensive stage small cell lung cancer</keyword>
</DOC>